Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99


Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression.

Jabbour M, Campbell EM, Fares H, Lybarger L.

J Immunol. 2009 Nov 15;183(10):6500-12. doi: 10.4049/jimmunol.0901521. Epub 2009 Oct 30.


Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1).

Corcoran K, Jabbour M, Bhagwandin C, Deymier MJ, Theisen DL, Lybarger L.

J Biol Chem. 2011 Oct 28;286(43):37168-80. doi: 10.1074/jbc.M110.204040. Epub 2011 Sep 6.


Autoregulation of MARCH1 expression by dimerization and autoubiquitination.

Bourgeois-Daigneault MC, Thibodeau J.

J Immunol. 2012 May 15;188(10):4959-70. doi: 10.4049/jimmunol.1102708. Epub 2012 Apr 16.


Altered MARCH1 ubiquination-regulated dendritic cell immune functions during the early stage of zymosan-induced multiple organ dysfunction syndrome (MODS) in mice.

Li F, Lu JY, Liu Q, Wang HW, Guo H.

Immunol Lett. 2013 Feb;150(1-2):105-15. doi: 10.1016/j.imlet.2012.12.012. Epub 2013 Jan 7.


CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation.

Tze LE, Horikawa K, Domaschenz H, Howard DR, Roots CM, Rigby RJ, Way DA, Ohmura-Hoshino M, Ishido S, Andoniou CE, Degli-Esposti MA, Goodnow CC.

J Exp Med. 2011 Jan 17;208(1):149-65. doi: 10.1084/jem.20092203. Epub 2011 Jan 10.


Identification of a novel motif that affects the conformation and activity of the MARCH1 E3 ubiquitin ligase.

Bourgeois-Daigneault MC, Thibodeau J.

J Cell Sci. 2013 Feb 15;126(Pt 4):989-98. doi: 10.1242/jcs.117804. Epub 2012 Dec 21.


MARCH1-mediated MHCII ubiquitination promotes dendritic cell selection of natural regulatory T cells.

Oh J, Wu N, Baravalle G, Cohn B, Ma J, Lo B, Mellman I, Ishido S, Anderson M, Shin JS.

J Exp Med. 2013 Jun 3;210(6):1069-77. doi: 10.1084/jem.20122695. Epub 2013 May 27.


Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells.

Ohmura-Hoshino M, Matsuki Y, Mito-Yoshida M, Goto E, Aoki-Kawasumi M, Nakayama M, Ohara O, Ishido S.

J Immunol. 2009 Dec 1;183(11):6893-7. doi: 10.4049/jimmunol.0902178. Epub 2009 Nov 16.


MARCH1 down-regulation in IL-10-activated B cells increases MHC class II expression.

Galbas T, Steimle V, Lapointe R, Ishido S, Thibodeau J.

Cytokine. 2012 Jul;59(1):27-30. doi: 10.1016/j.cyto.2012.03.015. Epub 2012 Apr 12.


Inhibition of MHC class II expression and immune responses by c-MIR.

Ohmura-Hoshino M, Matsuki Y, Aoki M, Goto E, Mito M, Uematsu M, Kakiuchi T, Hotta H, Ishido S.

J Immunol. 2006 Jul 1;177(1):341-54. Erratum in: J Immunol. 2006 Sep 1;177(5):3493.


Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.

Cho KJ, Walseng E, Ishido S, Roche PA.

Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10449-54. doi: 10.1073/pnas.1507981112. Epub 2015 Aug 3.


Endosomally stored MHC class II does not contribute to antigen presentation by dendritic cells at inflammatory conditions.

ten Broeke T, van Niel G, Wauben MH, Wubbolts R, Stoorvogel W.

Traffic. 2011 Aug;12(8):1025-36. doi: 10.1111/j.1600-0854.2011.01212.x. Epub 2011 May 13.


BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9.

Bakhru P, Sirisaengtaksin N, Soudani E, Mukherjee S, Khan A, Jagannath C.

Cell Immunol. 2014 Jan;287(1):53-61. doi: 10.1016/j.cellimm.2013.11.007. Epub 2013 Dec 11.


Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells.

Young LJ, Wilson NS, Schnorrer P, Proietto A, ten Broeke T, Matsuki Y, Mount AM, Belz GT, O'Keeffe M, Ohmura-Hoshino M, Ishido S, Stoorvogel W, Heath WR, Shortman K, Villadangos JA.

Nat Immunol. 2008 Nov;9(11):1244-52. doi: 10.1038/ni.1665. Epub 2008 Oct 12.


Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells.

Baravalle G, Park H, McSweeney M, Ohmura-Hoshino M, Matsuki Y, Ishido S, Shin JS.

J Immunol. 2011 Sep 15;187(6):2966-73. doi: 10.4049/jimmunol.1101643. Epub 2011 Aug 17.


Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes.

Thibodeau J, Bourgeois-Daigneault MC, Huppé G, Tremblay J, Aumont A, Houde M, Bartee E, Brunet A, Gauvreau ME, de Gassart A, Gatti E, Baril M, Cloutier M, Bontron S, Früh K, Lamarre D, Steimle V.

Eur J Immunol. 2008 May;38(5):1225-30. doi: 10.1002/eji.200737902.


MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation.

De Gassart A, Camosseto V, Thibodeau J, Ceppi M, Catalan N, Pierre P, Gatti E.

Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3491-6. doi: 10.1073/pnas.0708874105. Epub 2008 Feb 27.


MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the alpha- and beta-chains.

Théry C, Brachet V, Regnault A, Rescigno M, Ricciardi-Castagnoli P, Bonnerot C, Amigorena S.

J Immunol. 1998 Sep 1;161(5):2106-13.


Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination.

van Niel G, Wubbolts R, Ten Broeke T, Buschow SI, Ossendorp FA, Melief CJ, Raposo G, van Balkom BW, Stoorvogel W.

Immunity. 2006 Dec;25(6):885-94.

Items per page

Supplemental Content

Write to the Help Desk